HADH may be the target molecule of early vascular endothelial impairment in T2DM
BackgroundType 2 diabetes mellitus (T2DM) will significantly increase the risk of atherosclerosis (AS). Vascular endothelial cell dysfunction (VECD) is the foundation of AS. Early identification and intervention of VECD caused by T2DM can help us effectively delay or even suppress the occurrence of...
Main Authors: | Haowen Ye, Ruxin Wang, Jinjing Wei, Ying Wang, Lihong Wang, Xiaofang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.963916/full |
Similar Items
-
Bioinformatics Analysis Identifies Potential Ferroptosis Key Gene in Type 2 Diabetic Islet Dysfunction
by: Haowen Ye, et al.
Published: (2022-07-01) -
Glucotoxicity Activation of IL6 and IL11 and Subsequent Induction of Fibrosis May Be Involved in the Pathogenesis of Islet Dysfunction
by: Liqin Lu, et al.
Published: (2021-08-01) -
PTPLAD2 and USP49 Involved in the Pathogenesis of Smoke-Induced COPD by Integrative Bioinformatics Analysis
by: Zhang Q, et al.
Published: (2020-10-01) -
Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2
by: Shuai Huang, et al.
Published: (2021-03-01) -
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
by: Ji’an Yang, et al.
Published: (2020-03-01)